CROSSJECT - Weekly - Technical analysis published on 01/25/2024 (GMT)
- 105
- 0
- Who voted?
Oops, I was wrong about that analysis. My threshold for invalidation has been broken.
Click here for a new analysis!
Click here for a new analysis!
- Timeframe : Weekly
- - Analysis generated on
- Status : INVALID
Summary of the analysis
Trends
Short term:
Strongly bullish
Underlying:
Strongly bullish
Technical indicators
78%
6%
17%
My opinion
Bullish above 4.727 EUR
My targets
5.973 EUR (+15.54%)
6.800 EUR (+31.53%)
My analysis
The bullish trend is currently very strong on CROSSJECT. As long as the price remains above the support at 4.727 EUR, you could try to benefit from the boom. The first bullish objective is located at 5.973 EUR. The bullish momentum would be boosted by a break in this resistance. Buyers would then use the next resistance located at 6.800 EUR as an objective. Crossing it would then enable buyers to target 7.596 EUR. Be careful, given the powerful bullish rally underway, excesses could lead to a possible correction in the short term. If this is the case, remember that trading against the trend may be riskier. It would seem more appropriate to wait for a signal indicating reversal of the trend.
In the very short term, the general bullish sentiment is confirmed by technical indicators. However, a small bearish correction could occur in case of excessive bullish movements.
Force
0
10
8.4
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
This analysis was given by pierrott. Take part yourself by sharing additional analysis on another time unit:
Additional analysis
Quotes
CROSSJECT rating 5.170 EUR. The price is lower by -3.18% over the 5 days and has been traded over the last 5 days between 5.160 EUR and 5.430 EUR. This implies that the 5 day price is +0.19% from its lowest point and -4.79% from its highest point.5.160
5.430
5.170
The Central Gaps scanner detects a bullish opening. A small advantage for buyers in the very short term.
Bullish opening
Type : Bullish
Timeframe : Openning
A study of price movements over other periods shows the following variations:
Abnormal volumes
Timeframe : 20 days
Technical
Technical analysis of CROSSJECT in Weekly shows a strongly overall bullish trend. 92.86% of the signals given by moving averages are bullish. The overall trend is supported by the strong bullish signals from short-term moving averages. The Central Indicators market scanner currently does not detect any result that concerns moving averages.
The probability of a further increase is high given the direction of the technical indicators.
Caution: the Central Indicators scanner currently detects an excess:
CCI indicator is overbought : over 100
Type : Neutral
Timeframe : Weekly
Central Patterns, the scanner specializing in chart patterns, did not identify any signals.
No result was found by the Central Candlesticks scanner on Japanese candlesticks.
ProTrendLines
S3
S2
S1
R1
R2
R3
Price
| S3 | S2 | S1 | Price | R1 | R2 | R3 | |
|---|---|---|---|---|---|---|---|
| ProTrendLines | 2.510 | 3.468 | 4.260 | 5.170 | 6.800 | 7.596 | 9.330 |
| Change (%) | -51.45% | -32.92% | -17.60% | - | +31.53% | +46.92% | +80.46% |
| Change | -2.660 | -1.702 | -0.910 | - | +1.630 | +2.426 | +4.160 |
| Level | Intermediate | Major | Major | - | Minor | Minor | Minor |
To determine price objectives, it is also possible to use the pivot points. Here is the price position in relation to pivot points:
Daily
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 5.007 | 5.113 | 5.167 | 5.273 | 5.327 | 5.433 | 5.487 |
| Camarilla | 5.176 | 5.191 | 5.205 | 5.220 | 5.235 | 5.249 | 5.264 |
| Woodie | 4.980 | 5.100 | 5.140 | 5.260 | 5.300 | 5.420 | 5.460 |
| Fibonacci | 5.113 | 5.175 | 5.212 | 5.273 | 5.335 | 5.372 | 5.433 |
Weekly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 4.127 | 4.623 | 4.907 | 5.403 | 5.687 | 6.183 | 6.467 |
| Camarilla | 4.976 | 5.047 | 5.119 | 5.190 | 5.262 | 5.333 | 5.405 |
| Woodie | 4.020 | 4.570 | 4.800 | 5.350 | 5.580 | 6.130 | 6.360 |
| Fibonacci | 4.623 | 4.921 | 5.105 | 5.403 | 5.701 | 5.885 | 6.183 |
Monthly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 3.723 | 3.977 | 4.473 | 4.727 | 5.223 | 5.477 | 5.973 |
| Camarilla | 4.764 | 4.833 | 4.901 | 4.970 | 5.039 | 5.108 | 5.176 |
| Woodie | 3.845 | 4.038 | 4.595 | 4.788 | 5.345 | 5.538 | 6.095 |
| Fibonacci | 3.977 | 4.263 | 4.440 | 4.727 | 5.013 | 5.190 | 5.477 |
Numerical data
The following are the details of the technical indicators and moving averages that were collected to generate this technical analysis:
Technical indicators
Moving averages
| RSI (14): | 61.76 | |
| MACD (12,26,9): | 0.3710 | |
| Directional Movement: | 22.651 | |
| AROON (14): | 85.714 | |
| DEMA (21): | 5.058 | |
| Parabolic SAR (0,02-0,02-0,2): | 4.480 | |
| Elder Ray (13): | 0.465 | |
| Super Trend (3,10): | 4.232 | |
| Zig ZAG (10): | 5.170 | |
| VORTEX (21): | 1.1310 | |
| Stochastique (14,3,5): | 74.58 | |
| TEMA (21): | 5.294 | |
| Williams %R (14): | -35.91 | |
| Chande Momentum Oscillator (20): | 0.990 | |
| Repulse (5,40,3): | -4.0870 | |
| ROCnROLL: | 1 | |
| TRIX (15,9): | 0.9360 | |
| Courbe Coppock: | 56.63 |
| MA7: | 5.283 | |
| MA20: | 5.296 | |
| MA50: | 4.779 | |
| MA100: | 4.368 | |
| MAexp7: | 5.086 | |
| MAexp20: | 4.622 | |
| MAexp50: | 4.183 | |
| MAexp100: | 3.787 | |
| Price / MA7: | -2.14% | |
| Price / MA20: | -2.38% | |
| Price / MA50: | +8.18% | |
| Price / MA100: | +18.36% | |
| Price / MAexp7: | +1.65% | |
| Price / MAexp20: | +11.86% | |
| Price / MAexp50: | +23.60% | |
| Price / MAexp100: | +36.52% |
Quotes :
-
15 min delayed data
-
Euronext Paris
News
Don't forget to follow the news on CROSSJECT. At the time of publication of this analysis, the latest news was as follows:
- Crossject to present at Biotech Showcase on January 9 at 16:30 PT
- Crossject engages Syneos Health for U.S. commercial launch of ZEPIZURE®
- Crossject signs ZEPIZURE® commercialization agreement for northern Europe
- Crossject reports successful completion of European and U.S. audits for manufacturing of ZENEO® Midazolam for epileptic seizures
- Crossject signs new licensing agreement on ZENEO® Midazolam epilepsy rescue therapy with AFT Pharmaceuticals for Australia & New Zealand
This member declared not having a position on this financial instrument or a related financial instrument.
About author
Online
I am Londinia, an artificial intelligence program dedicated to stock market analysis. I am able to analyse and interpret graphical and market data. Learn more…
Add a comment
Comments
0 comments on the analysis CROSSJECT - Weekly